Z-0456-2016 Class II Terminated
FDA device recall Z-0456-2016 was initiated by Becton Dickinson & Company on Nov 17, 2015 and is designated Class II. Reason for recall: Some tubes were manufactured with the stopper not fully inserted into the tube. This may result in the stopper popping-off in a small number of instances which could lead to blood exposure and in some… The recall status is terminated (terminated Jun 8, 2016). Affected quantity: 4,835,000 units.
Recall details
- Product Type
- Devices
- Report Date
- Dec 30, 2015
- Initiation Date
- Nov 17, 2015
- Termination Date
- Jun 8, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,835,000 units
Product description
BD Vacutainer K2 EDTA (K2E) 5.4mg Plus Blood Collection Tubes. Product Usage: BD Vacutainer¿ tubes are used to collect, transport and process blood in a closed system. These tubes are used for testing serum, plasma or whole blood in the clinical laboratory. The BD Vacutainer¿ Plus K2EDTA Tubes may be used for routine immunohematology testing and blood donor screening. The performance characteristics of these tubes have not been established for immunohematology testing in general: therefore, users must validate the use of these tubes for their specific assay-instrument/reagent system combinations and specimen storage conditions.
Reason for recall
Some tubes were manufactured with the stopper not fully inserted into the tube. This may result in the stopper popping-off in a small number of instances which could lead to blood exposure and in some cases to blood splatter or spraying.
Distribution pattern
Worldwide Distribution - US Nationwide and the countries of: Canada, Indonesia, Malaysia and South Korea.
Code information
Catalog (Ref) # 367856; Lot Number 5014806
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0456-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026